Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR

Japanese bacillus Calmette–Guerin (BCG) vaccine preparation contains two types of variant strains, Type I, which has a 22-base-pair deletion in the RD16 region, and Type II, which has an identical sequence to those of other BCG strains. In this study, we established a method to quantify the percenta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biologicals 2007-04, Vol.35 (2), p.139-143
Hauptverfasser: Shibayama, Keigo, Mochida, Keiko, Yagi, Tetsuya, Mori, Shigetaro, Arakawa, Yoshichika, Yamamoto, Saburo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 143
container_issue 2
container_start_page 139
container_title Biologicals
container_volume 35
creator Shibayama, Keigo
Mochida, Keiko
Yagi, Tetsuya
Mori, Shigetaro
Arakawa, Yoshichika
Yamamoto, Saburo
description Japanese bacillus Calmette–Guerin (BCG) vaccine preparation contains two types of variant strains, Type I, which has a 22-base-pair deletion in the RD16 region, and Type II, which has an identical sequence to those of other BCG strains. In this study, we established a method to quantify the percentage of variant strain Type II contained in freeze-dried BCG product with real-time PCR. With this method we examined the master seed lot Tokyo 172, two secondary seed lots, Tokyo 172-1 and Tokyo 172-2, which were produced from Tokyo 172, and four commercial lots produced form Tokyo 172-1. Tokyo 172, Tokyo 172-1, and Tokyo 172-2 contained 55.1%, 19.5%, and 3.6% of Type II variant strain, respectively. Commercial lots contained 1.5%, 4.5%, 7.4%, and 4.3% of Type II variant strain, respectively. These results indicated that the two variant strains contained in the master seed lot continued to coexist in subsequently produced lots with a decrease in population of variant strain Type II. This method would be useful for quality control of commercial Japanese BCG vaccine preparations.
doi_str_mv 10.1016/j.biologicals.2006.07.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70307407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1045105606000893</els_id><sourcerecordid>70307407</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-a38f4d8846c6a4477c4bad7522fd8c630f4e885df7589e18bfc9b7c90965bfe63</originalsourceid><addsrcrecordid>eNqNkcuO1DAQRS0EYoaBX0Bmwy6hnPi5hAgG0Eg8BGvLccrIrXScsdODhq_HrW4JdrByuXTurVJdQl4waBkw-WrXjjHN6Uf0bi5tByBbUC2AeEAuGRjR6L6Dh8eai4aBkBfkSSk7AMa44o_JBVOguABzSW6_HNyyxVCttpgWmgLdfiZ653KsfVq27OJSqE_LVgucaFxoyIi_sJlyrP-PbnULFqRvhusq875SdM24unxyHO9pRjc3W9wj_Tx8fUoehbo2Pju_V-T7u7ffhvfNzafrD8Prm8Zz1W2N63Xgk9Zceuk4V8rz0U1KdF2YtJc9BI5aiykooQ0yPQZvRuUNGCnGgLK_Ii9PvmtOtwcsm93H4nGe67rpUKyCvh4B1D9BZnTfc2kqaE6gz6mUjMGuOe5dvrcM7DEYu7N_BWOPwVhQtgZTtc_PQw7jHqc_ynMSFRhOANab3EXMtviIi8cpZvSbnVL8jzG_AcsFpl4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19833469</pqid></control><display><type>article</type><title>Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shibayama, Keigo ; Mochida, Keiko ; Yagi, Tetsuya ; Mori, Shigetaro ; Arakawa, Yoshichika ; Yamamoto, Saburo</creator><creatorcontrib>Shibayama, Keigo ; Mochida, Keiko ; Yagi, Tetsuya ; Mori, Shigetaro ; Arakawa, Yoshichika ; Yamamoto, Saburo</creatorcontrib><description>Japanese bacillus Calmette–Guerin (BCG) vaccine preparation contains two types of variant strains, Type I, which has a 22-base-pair deletion in the RD16 region, and Type II, which has an identical sequence to those of other BCG strains. In this study, we established a method to quantify the percentage of variant strain Type II contained in freeze-dried BCG product with real-time PCR. With this method we examined the master seed lot Tokyo 172, two secondary seed lots, Tokyo 172-1 and Tokyo 172-2, which were produced from Tokyo 172, and four commercial lots produced form Tokyo 172-1. Tokyo 172, Tokyo 172-1, and Tokyo 172-2 contained 55.1%, 19.5%, and 3.6% of Type II variant strain, respectively. Commercial lots contained 1.5%, 4.5%, 7.4%, and 4.3% of Type II variant strain, respectively. These results indicated that the two variant strains contained in the master seed lot continued to coexist in subsequently produced lots with a decrease in population of variant strain Type II. This method would be useful for quality control of commercial Japanese BCG vaccine preparations.</description><identifier>ISSN: 1045-1056</identifier><identifier>EISSN: 1095-8320</identifier><identifier>DOI: 10.1016/j.biologicals.2006.07.005</identifier><identifier>PMID: 17074509</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Bacillus Calmette–Guerin ; Base Sequence ; BCG Vaccine - genetics ; Freeze Drying ; Genetic Variation ; Japan ; Molecular Sequence Data ; Mycobacterium bovis - genetics ; Nucleic Acid Probes - chemistry ; Polymerase Chain Reaction ; Quality Control ; Quantification ; Real-time PCR ; Sequence Homology, Nucleic Acid ; Variant strain</subject><ispartof>Biologicals, 2007-04, Vol.35 (2), p.139-143</ispartof><rights>2006 The International Association for Biologicals</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-a38f4d8846c6a4477c4bad7522fd8c630f4e885df7589e18bfc9b7c90965bfe63</citedby><cites>FETCH-LOGICAL-c472t-a38f4d8846c6a4477c4bad7522fd8c630f4e885df7589e18bfc9b7c90965bfe63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1045105606000893$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17074509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shibayama, Keigo</creatorcontrib><creatorcontrib>Mochida, Keiko</creatorcontrib><creatorcontrib>Yagi, Tetsuya</creatorcontrib><creatorcontrib>Mori, Shigetaro</creatorcontrib><creatorcontrib>Arakawa, Yoshichika</creatorcontrib><creatorcontrib>Yamamoto, Saburo</creatorcontrib><title>Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR</title><title>Biologicals</title><addtitle>Biologicals</addtitle><description>Japanese bacillus Calmette–Guerin (BCG) vaccine preparation contains two types of variant strains, Type I, which has a 22-base-pair deletion in the RD16 region, and Type II, which has an identical sequence to those of other BCG strains. In this study, we established a method to quantify the percentage of variant strain Type II contained in freeze-dried BCG product with real-time PCR. With this method we examined the master seed lot Tokyo 172, two secondary seed lots, Tokyo 172-1 and Tokyo 172-2, which were produced from Tokyo 172, and four commercial lots produced form Tokyo 172-1. Tokyo 172, Tokyo 172-1, and Tokyo 172-2 contained 55.1%, 19.5%, and 3.6% of Type II variant strain, respectively. Commercial lots contained 1.5%, 4.5%, 7.4%, and 4.3% of Type II variant strain, respectively. These results indicated that the two variant strains contained in the master seed lot continued to coexist in subsequently produced lots with a decrease in population of variant strain Type II. This method would be useful for quality control of commercial Japanese BCG vaccine preparations.</description><subject>Bacillus Calmette–Guerin</subject><subject>Base Sequence</subject><subject>BCG Vaccine - genetics</subject><subject>Freeze Drying</subject><subject>Genetic Variation</subject><subject>Japan</subject><subject>Molecular Sequence Data</subject><subject>Mycobacterium bovis - genetics</subject><subject>Nucleic Acid Probes - chemistry</subject><subject>Polymerase Chain Reaction</subject><subject>Quality Control</subject><subject>Quantification</subject><subject>Real-time PCR</subject><subject>Sequence Homology, Nucleic Acid</subject><subject>Variant strain</subject><issn>1045-1056</issn><issn>1095-8320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcuO1DAQRS0EYoaBX0Bmwy6hnPi5hAgG0Eg8BGvLccrIrXScsdODhq_HrW4JdrByuXTurVJdQl4waBkw-WrXjjHN6Uf0bi5tByBbUC2AeEAuGRjR6L6Dh8eai4aBkBfkSSk7AMa44o_JBVOguABzSW6_HNyyxVCttpgWmgLdfiZ653KsfVq27OJSqE_LVgucaFxoyIi_sJlyrP-PbnULFqRvhusq875SdM24unxyHO9pRjc3W9wj_Tx8fUoehbo2Pju_V-T7u7ffhvfNzafrD8Prm8Zz1W2N63Xgk9Zceuk4V8rz0U1KdF2YtJc9BI5aiykooQ0yPQZvRuUNGCnGgLK_Ii9PvmtOtwcsm93H4nGe67rpUKyCvh4B1D9BZnTfc2kqaE6gz6mUjMGuOe5dvrcM7DEYu7N_BWOPwVhQtgZTtc_PQw7jHqc_ynMSFRhOANab3EXMtviIi8cpZvSbnVL8jzG_AcsFpl4</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Shibayama, Keigo</creator><creator>Mochida, Keiko</creator><creator>Yagi, Tetsuya</creator><creator>Mori, Shigetaro</creator><creator>Arakawa, Yoshichika</creator><creator>Yamamoto, Saburo</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR</title><author>Shibayama, Keigo ; Mochida, Keiko ; Yagi, Tetsuya ; Mori, Shigetaro ; Arakawa, Yoshichika ; Yamamoto, Saburo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-a38f4d8846c6a4477c4bad7522fd8c630f4e885df7589e18bfc9b7c90965bfe63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Bacillus Calmette–Guerin</topic><topic>Base Sequence</topic><topic>BCG Vaccine - genetics</topic><topic>Freeze Drying</topic><topic>Genetic Variation</topic><topic>Japan</topic><topic>Molecular Sequence Data</topic><topic>Mycobacterium bovis - genetics</topic><topic>Nucleic Acid Probes - chemistry</topic><topic>Polymerase Chain Reaction</topic><topic>Quality Control</topic><topic>Quantification</topic><topic>Real-time PCR</topic><topic>Sequence Homology, Nucleic Acid</topic><topic>Variant strain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shibayama, Keigo</creatorcontrib><creatorcontrib>Mochida, Keiko</creatorcontrib><creatorcontrib>Yagi, Tetsuya</creatorcontrib><creatorcontrib>Mori, Shigetaro</creatorcontrib><creatorcontrib>Arakawa, Yoshichika</creatorcontrib><creatorcontrib>Yamamoto, Saburo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biologicals</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shibayama, Keigo</au><au>Mochida, Keiko</au><au>Yagi, Tetsuya</au><au>Mori, Shigetaro</au><au>Arakawa, Yoshichika</au><au>Yamamoto, Saburo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR</atitle><jtitle>Biologicals</jtitle><addtitle>Biologicals</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>35</volume><issue>2</issue><spage>139</spage><epage>143</epage><pages>139-143</pages><issn>1045-1056</issn><eissn>1095-8320</eissn><abstract>Japanese bacillus Calmette–Guerin (BCG) vaccine preparation contains two types of variant strains, Type I, which has a 22-base-pair deletion in the RD16 region, and Type II, which has an identical sequence to those of other BCG strains. In this study, we established a method to quantify the percentage of variant strain Type II contained in freeze-dried BCG product with real-time PCR. With this method we examined the master seed lot Tokyo 172, two secondary seed lots, Tokyo 172-1 and Tokyo 172-2, which were produced from Tokyo 172, and four commercial lots produced form Tokyo 172-1. Tokyo 172, Tokyo 172-1, and Tokyo 172-2 contained 55.1%, 19.5%, and 3.6% of Type II variant strain, respectively. Commercial lots contained 1.5%, 4.5%, 7.4%, and 4.3% of Type II variant strain, respectively. These results indicated that the two variant strains contained in the master seed lot continued to coexist in subsequently produced lots with a decrease in population of variant strain Type II. This method would be useful for quality control of commercial Japanese BCG vaccine preparations.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>17074509</pmid><doi>10.1016/j.biologicals.2006.07.005</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1045-1056
ispartof Biologicals, 2007-04, Vol.35 (2), p.139-143
issn 1045-1056
1095-8320
language eng
recordid cdi_proquest_miscellaneous_70307407
source MEDLINE; Elsevier ScienceDirect Journals
subjects Bacillus Calmette–Guerin
Base Sequence
BCG Vaccine - genetics
Freeze Drying
Genetic Variation
Japan
Molecular Sequence Data
Mycobacterium bovis - genetics
Nucleic Acid Probes - chemistry
Polymerase Chain Reaction
Quality Control
Quantification
Real-time PCR
Sequence Homology, Nucleic Acid
Variant strain
title Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T09%3A56%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantification%20of%20two%20variant%20strains%20contained%20in%20freeze-dried%20Japanese%20BCG%20vaccine%20preparation%20by%20real-time%20PCR&rft.jtitle=Biologicals&rft.au=Shibayama,%20Keigo&rft.date=2007-04-01&rft.volume=35&rft.issue=2&rft.spage=139&rft.epage=143&rft.pages=139-143&rft.issn=1045-1056&rft.eissn=1095-8320&rft_id=info:doi/10.1016/j.biologicals.2006.07.005&rft_dat=%3Cproquest_cross%3E70307407%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19833469&rft_id=info:pmid/17074509&rft_els_id=S1045105606000893&rfr_iscdi=true